Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
30.60
+0.10 (0.33%)
Mar 6, 2026, 11:10 AM EST - Market open
Sensei Biotherapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$72.50
Upside
+136.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $30 | Strong Buy | Maintains | $5 → $30 | -1.96% | Aug 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +226.80% | Jun 2, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $70 → $80 | Buy | Maintains | $70 → $80 | +161.44% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +161.44% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +161.44% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 | Strong Buy | Maintains | $80 | +161.44% | Jan 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +161.44% | Aug 7, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +161.44% | Jun 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +161.44% | May 24, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $100 | Buy | Reiterates | $100 | +226.80% | May 24, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $100 | Buy | Initiates | $100 | +226.80% | May 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +161.44% | Dec 4, 2023 |
| Citigroup | Citigroup | Strong Buy Initiates $120 | Strong Buy | Initiates | $120 | +292.16% | Dec 13, 2022 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $100 | Hold → Buy | Upgrades | $100 | +226.80% | Oct 3, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $240 → $200 | Buy | Maintains | $240 → $200 | +553.59% | Mar 10, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.